|
Hereditary elliptocytosis
Definition
Hereditary elliptocytosis is a disorder passed down through families in which the red blood cells are abnormally shaped.
See also:
Alternative Names
Elliptocytosis - hereditary
Causes
Elliptocytosis affects about 1 in every 2,500 people of northern European heritage. It is more common in people of African and Mediterranean descent. You are more likely to develop this condition if someone in your family has had it.
Symptoms
- Fatigue
- Shortness of breath
- Yellow skin and eyes (jaundice) - may persist for a long time in a newborn
Exams and Tests
An examination by your health care provider may occasionally show an enlarged spleen.
The following tests may help diagnose the condition:
- Bilirubin level may be high.
- Blood smear may show elliptical red blood cells.
- Complete blood count (CBC) may show anemia or signs of red blood cell destruction.
- Lactate dehydrogenase level may be high.
- Ultrasound of the gallbladder may show gallstones.
Treatment
There is no treatment needed for the disorder unless severe anemia or anemia symptoms occur. Surgery to remove the spleen may decrease the rate of red blood cell damage.
Outlook (Prognosis)
Most persons with hereditary elliptocytosis have no problems, and are unaware of their condition.
Possible Complications
Elliptocytosis is frequently harmless. In mild cases, fewer than 15% of red blood cells are elliptical-shaped. However, some people may have crises in which the red blood cells rupture, especially if they have a viral infection. Persons with this disease can develop anemia, jaundice, and gallstones.
When to Contact a Medical Professional
Call for an appointment with your health care provider if you have jaundice that doesn't go away or symptoms of anemia or gallstones.
Prevention
Genetic counseling may be appropriate for persons with a family history of this disease who wish to become parents.
References
Gallagher PG. Hemolytic anemias: red cell membrane and metabolic defects In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 164.
Reviewed By: Todd Gersten, MD, Hematology/Oncology, Palm Beach Cancer Institute, West Palm Beach, FL. Review provided by VeriMed Healthcare Network; Linda J. Vorvick, MD, Medical Director and Director of Didactic Curriculum, MEDEX Northwest Division of Physician Assistant Studies, Department of Family Medicine, UW Medicine, School of Medicine, University of Washington. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
